IRONWOOD PHARMACEUTICALS INC Income Statement
IRWD / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 15 fiscal years. All figures from audited SEC 10-K filings.
IRONWOOD PHARMACEUTICALS INC reported $296M in revenue and $24M in net income for FY2025. Revenue has grown at a 11.3% compound annual rate over the past 14 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $296.2M | $410.6M | $442.7M | $389.5M | $413.8M | $346.6M | $428.4M | $274.0M | $52.2M | $274.0M | $149.6M | $76.4M | $65.9M | $150.2M | $65.9M |
| Cost of Revenue | - | - | - | $3.1M | - | $32.8M | $23.9M | $1.9M | $19.1M | $1.9M | $12.0K | $5.3M | $965.0K | $965.0K | - |
| SG&A Expense | $82.3M | $116.0M | $158.3M | $140.0M | $111.1M | $219.7M | $172.4M | $173.3M | $231.2M | $173.3M | $125.2M | $118.3M | $45.9M | $92.5M | $45.9M |
| R&D Expense | $95.1M | $44.3M | $116.1M | $88.1M | $70.4M | $101.1M | $115.0M | $139.5M | $88.1M | $139.5M | $108.7M | $101.9M | $86.1M | $113.5M | $86.1M |
| Operating Income | $98.5M | $250.3M | -$945.4M | $142.9M | $232.3M | -$150.7M | $120.1M | -$51.9M | -$15.4M | -$51.9M | -$102.1M | -$169.4M | -$66.1M | -$72.8M | -$66.1M |
| Interest Expense | - | - | $21.6M | $29.5M | $31.1M | $37.7M | $36.6M | $39.2M | $36.4M | $39.2M | $31.1M | $21.2M | $63.0K | $59.0K | $63.0K |
| Income Tax | $46.0M | $77.4M | $83.5M | $2.7M | -$327.8M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $3.0K | - | $3.0K |
| Net Income | $24.0M | $175.1M | -$1.0B | $106.2M | $528.4M | -$282.4M | $21.5M | -$81.7M | -$116.9M | -$81.7M | -$142.7M | - | - | -$72.6M | -$64.9M |
| EPS (Basic) | $0.01 | $1.13 | $3.26 | $0.67 | $0.14 | -$1.85 | -$0.38 | - | - | - | - | - | -$0.68 | -$0.65 | - |
| EPS (Diluted) | $0.01 | $0.96 | $3.21 | $0.66 | $0.14 | -$1.85 | -$0.38 | -$0.56 | -$1.00 | -$1.39 | -$2.35 | -$0.68 | -$0.68 | -$0.65 | -$10.00 |
| Shares Outstanding | 160.2M | 156.4M | 154.0M | 162.0M | 160.6M | 157.5M | 154.4M | 144.9M | 142.2M | 136.8M | 115.9M | 106.4M | 99.9M | 89.7M | 7.1M |
| Operating Margin | 33.3% | 61.0% | -213.5% | 36.7% | 56.1% | -43.5% | 28.0% | -18.9% | -29.4% | -18.9% | -68.3% | -221.6% | -100.4% | -48.4% | -100.4% |
| Profit Margin | 8.1% | 42.6% | -226.4% | 27.3% | 127.7% | -81.5% | 5.0% | -29.8% | -224.2% | -29.8% | -95.4% | - | - | -48.3% | -98.5% |